Paul Moss Shares Insights from RWE Inform Study from AstraZeneca at IDWeek 2023

Shots: Paul Moss Professor of Hematology and Deputy Head of the College of Medicine at the University of Birmingham, shares insights from the RWE INFORM study from AstraZeneca INFORM used record data from 12 million people in the UK to study the relative risk of severe COVID-19 infection in patients with immune suppression Even though…

BySaurabh ChaubeyDecember 18, 2023

THOUGHTSPOT

Role of Real World Evidence in Pharma (RWE in Pharma)

Shots: Real-world evidence (RWE) aims to mitigate the limitations of randomized controlled trials (RCTs) by keeping a constant vigil on the safety and effectiveness of drugs in real-world settings Phrases such as Real-world data, Randomized Controlled Trials, and Real-World Evidence hold a degree of paramount importance when it comes to safeguarding the health of individuals…

BySaurabh ChaubeyDecember 12, 2023

VIEWPOINTS

Helen Yeh & Naim Shehadeh in a Stirring Conversation with PharmaShots, Highlight the Results from T2NOW Study

Shots: At the EASD, AZ announced positive results from the T2NOW P-III study that evaluated the efficacy and safety of Forxiga as an add-on treatment in children and adolescents with T2D receiving metformin, insulin, or both Helen Yeh, VP, CVRM Therapy Area Biopharmaceuticals Medical at AstraZeneca, and Naim Shehadeh, Professor of Endocrinology, Rambam Health Care…

BySaurabh ChaubeyDecember 11, 2023

EVENTS

Webinar Recap: Successful Drug Discovery-Collaboration Among Multiple Functions

Illuminating, informative, and engaging, our recent webinar on Successful Drug Discovery-Collaboration Among Multiple Functions with Eurofins Advinus, was an energy-packed session that highlighted the intricacies of the drug discovery process. The webinar delved deep into the nuances that are necessary for a successful drug discovery. The session was filled with stimulating case studies, highlighting crucial aspects like…

BySaurabh ChaubeyDecember 8, 2023

VIEWPOINTS

Kylen Cieslak and Robert Ley Discuss the Expansion of Thermo Fisher Scientific’s Services Central in the US & EU

Shots: Kylen Cieslak, Senior Manager, Service Marketing, Thermo Fisher Scientific, and Robert Ley, Senior Strategic Product Manager, Thermo Fisher Scientific in a stirring conversation with PharmaShots Kylen and Robert highlighted the recent expansion of Thermo Fisher Scientific’s Services Central in the United States and Europe Services Central is an online platform intended to provide 24/7…

BySaurabh ChaubeyDecember 7, 2023

VIEWPOINTS

Unlocking Approval: Mohamed Eid Dives into the Exciting Approval of Jardiance for Adult CKD Treatment in a Captivating Chat with PharmaShots

Shots: Mohamed Eid, VP of Clinical Development & Medical Affairs, Cardio-Renal-Metabolism & Respiratory Medicine, at Boehringer Ingelheim, in a stimulating conversation with PharmaShots sheds light on the recent approval of Jardiance for the treatment of adults with chronic kidney disease Jardiance’s EMPA Kidney P-III trial results demonstrated a 28% relative risk reduction vs placebo. Jardiance…

BySaurabh ChaubeyDecember 5, 2023

VIEWPOINTS

Andrew Menzies-Gow Shares Insights from Phase III MANDARA Trial of Fasenra for EGPA Patients

Shots While sharing the details on Fasenra, Andrew highlights the unmet medical need in the healthcare sector as there’s only one approved treatment for EGPA With mepolizumab as the comparator drug for the trial, Andrew shares the positive results in achieving remission rates. Andrew sheds light on the unique mechanism of benralizumab that directly targets…

BySaurabh ChaubeyDecember 4, 2023

VIEWPOINTS

In an Insightful Conversation with PharmaShots, Betty Woo Highlights Thermo Fisher’s Cell Therapy Collaboration Program

Shots: Betty Woo, VP of Cell, Gene, and Advanced Therapies, Thermo Fisher Scientific discusses the evolution of ThermoFisher’s strategic collaboration with ArsenalBio Betty highlights the development of programmable autologous T cells for the treatment of cancer and the cell therapy collaboration program Betty believes that through innovation and partnership, they can tap into the full…

BySaurabh ChaubeyNovember 30, 2023

VIEWPOINTS

Moitreyee Chatterjee-Kishore, in an absorbing conversation with PharmaShots, shares the highlights of the SPOTLIGHT & GLOW study

Shots: Moitreyee Chatterjee-Kishore, HOD, Immuno-Oncology & Cancer Cell Therapy at Astellas shares insights from the P-III trials (SPOTLIGHT & GLOW) In SPOTLIGHT and GLOW, zolbetuximab and chemotherapy demonstrated improved PFS and OS vs placebo plus chemotherapy, yielding positive outcomes for patients with advanced gastric or GEJ cancer. Moitreyee highlights the ongoing clinical trials for the…

BySaurabh ChaubeyNovember 29, 2023

VIEWPOINTS

Michael Irizarry shares insights from the P-III clinical study of LEQEMBI, for the treatment of Alzheimer’s disease

Shots: Michael Irizarry, Senior VP of Clinical Research and Deputy Chief Clinical Officer, Alzheimer’s Disease and Brain Health at Eisai in a stimulating conversation with PharmaShots Michael shares insights from the P-III clinical study Clarity AD of LEQEMBI for the treatment of Alzheimer’s disease The study highlights that LEQEMBI treatment met the primary endpoint and…

BySaurabh ChaubeyNovember 27, 2023

Saurabh Chaubey

Paul Moss Shares Insights from RWE Inform Study from AstraZeneca at IDWeek 2023

Role of Real World Evidence in Pharma (RWE in Pharma)

Helen Yeh & Naim Shehadeh in a Stirring Conversation with PharmaShots, Highlight the Results from T2NOW Study

Webinar Recap: Successful Drug Discovery-Collaboration Among Multiple Functions

Kylen Cieslak and Robert Ley Discuss the Expansion of Thermo Fisher Scientific’s Services Central in the US & EU

Unlocking Approval: Mohamed Eid Dives into the Exciting Approval of Jardiance for Adult CKD Treatment in a Captivating Chat with PharmaShots

Andrew Menzies-Gow Shares Insights from Phase III MANDARA Trial of Fasenra for EGPA Patients

In an Insightful Conversation with PharmaShots, Betty Woo Highlights Thermo Fisher’s Cell Therapy Collaboration Program

Moitreyee Chatterjee-Kishore, in an absorbing conversation with PharmaShots, shares the highlights of the SPOTLIGHT & GLOW study

Michael Irizarry shares insights from the P-III clinical study of LEQEMBI, for the treatment of Alzheimer’s disease

Contact US

FOLLOW US